C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis
نویسندگان
چکیده
منابع مشابه
C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis.
OBJECTIVE RA is a chronic autoimmune inflammatory condition associated with increased cardiovascular morbidity and mortality. Endothelial dysfunction, a marker of early atherosclerotic disease, occurs in some inflammatory diseases but this relationship has not been previously explored within the microvasculature of patients with RA. We therefore assessed forearm microvascular endothelial functi...
متن کاملRole of C-reactive protein in osteoclastogenesis in rheumatoid arthritis
INTRODUCTION C-reactive protein (CRP) is one of the biomarkers for the diagnosis and assessment of disease activity in rheumatoid arthritis (RA). CRP is not only the by-product of inflammatory response, but also plays proinflammatory and prothrombotic roles. The aim of this study was to determine the role of CRP on bone destruction in RA. METHODS CRP levels in RA synovial fluid (SF) and serum...
متن کاملthe effect of quercetin on plasma oxidative status, c-reactive protein and blood pressure in women with rheumatoid arthritis
-
متن کاملA neurosurgically reversible cause of respiratory dysfunction in rheumatoid arthritis.
Accepted 10 March 1998 A 69-year-old woman had been diagnosed with rheumatoid-factor-positive, antinuclearantibody-negative, erosive rheumatoid arthritis in 1971 at the age of 44 years. She was managed originally on a combination of adrenocorticotropin, given at intervals, and nonsteroidal anti-inflammatory drugs but, by 1973, also required prednisolone. In 1977 there was progression of erosive...
متن کاملC reactive protein and microvascular function.
Emerging data suggest that C reactive protein may be a mediator as well as a marker of atherosclerosis
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rheumatology
سال: 2008
ISSN: 1462-0324,1462-0332
DOI: 10.1093/rheumatology/ken386